Xiaohong Shu

2.2k total citations
63 papers, 1.8k citations indexed

About

Xiaohong Shu is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Xiaohong Shu has authored 63 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 16 papers in Oncology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Xiaohong Shu's work include Sirtuins and Resveratrol in Medicine (12 papers), Cancer Mechanisms and Therapy (8 papers) and Receptor Mechanisms and Signaling (5 papers). Xiaohong Shu is often cited by papers focused on Sirtuins and Resveratrol in Medicine (12 papers), Cancer Mechanisms and Therapy (8 papers) and Receptor Mechanisms and Signaling (5 papers). Xiaohong Shu collaborates with scholars based in China, United States and United Kingdom. Xiaohong Shu's co-authors include Chuangang Li, Xiaodong Ma, Kexin Liu, Changyuan Wang, Mo‐Li Wu, Molin Li, Sa Deng, Qing‐You Kong, Xiaohong Chen and Fang Liu and has published in prestigious journals such as Angewandte Chemie International Edition, The Journal of Immunology and PLoS ONE.

In The Last Decade

Xiaohong Shu

61 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohong Shu China 26 934 315 296 290 189 63 1.8k
Andrea Lapucci Italy 24 1.1k 1.1× 378 1.2× 196 0.7× 198 0.7× 81 0.4× 54 1.7k
Xinqun Li United States 23 957 1.0× 519 1.6× 432 1.5× 193 0.7× 60 0.3× 33 2.0k
Ye Xu China 32 1.3k 1.4× 276 0.9× 282 1.0× 67 0.2× 87 0.5× 77 2.5k
Clemens Zwergel Italy 27 1.1k 1.2× 293 0.9× 225 0.8× 90 0.3× 388 2.1× 69 1.9k
Anait S. Levenson United States 32 1.9k 2.0× 638 2.0× 661 2.2× 522 1.8× 211 1.1× 63 3.1k
Tohru Yamamori Japan 26 1.4k 1.5× 252 0.8× 290 1.0× 496 1.7× 81 0.4× 58 2.8k
Yu‐Pei Yuan China 23 1.2k 1.2× 356 1.1× 358 1.2× 94 0.3× 54 0.3× 31 2.4k
Maria Luisa Panno Italy 29 1.0k 1.1× 661 2.1× 476 1.6× 67 0.2× 123 0.7× 54 2.3k
Junlian Gu China 26 1.2k 1.3× 207 0.7× 265 0.9× 107 0.4× 52 0.3× 57 1.9k

Countries citing papers authored by Xiaohong Shu

Since Specialization
Citations

This map shows the geographic impact of Xiaohong Shu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Shu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Shu more than expected).

Fields of papers citing papers by Xiaohong Shu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohong Shu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Shu. The network helps show where Xiaohong Shu may publish in the future.

Co-authorship network of co-authors of Xiaohong Shu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohong Shu. A scholar is included among the top collaborators of Xiaohong Shu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohong Shu. Xiaohong Shu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ning, Jing, Zhenhao Tian, Jiayue Wang, et al.. (2024). Rational Molecular Design of a Fluorescent Probe for Selectively Sensing Human Cytochrome P450 2D6. Angewandte Chemie. 136(41).
2.
Shopit, Abdullah, Shisheng Wang, Mohammed Safi, et al.. (2021). Enhancement of gemcitabine efficacy by K73-03 via epigenetically regulation of miR-421/SPINK1 in gemcitabine resistant pancreatic cancer cells. Phytomedicine. 91. 153711–153711. 5 indexed citations
3.
Wang, Xun, Min Liu, Huilian Huang, et al.. (2020). Triptolidenol, isolated from Tripterygium wilfordii, disrupted NF-κB/COX-2 pathway by targeting ATP-binding sites of IKKβ in clear cell renal cell carcinoma. Fitoterapia. 148. 104779–104779. 13 indexed citations
4.
Wang, Luhong, Min Ai, Jiawen Yu, et al.. (2019). Structure-based modification of carbonyl-diphenylpyrimidines (Car-DPPYs) as a novel focal adhesion kinase (FAK) inhibitor against various stubborn cancer cells. European Journal of Medicinal Chemistry. 172. 154–162. 31 indexed citations
5.
Yang, Yang, Guangyuan Zhang, Chuangang Li, et al.. (2019). <p>Metabolic profile and structure–activity relationship of resveratrol and its analogs in human bladder cancer cells</p>. Cancer Management and Research. Volume 11. 4631–4642. 21 indexed citations
6.
Zhang, En Xia, Lei Shi, Xin Guo, et al.. (2019). 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer. Life Sciences. 238. 116938–116938. 13 indexed citations
7.
Wu, Mo‐Li, Danyang Song, Hui Li, et al.. (2019). <p>Negative regulators of STAT3 signaling pathway in cancers</p>. Cancer Management and Research. Volume 11. 4957–4969. 52 indexed citations
8.
Chen, Lixue, Ning Wang, Wěi Li, et al.. (2018). The synthesis of 4-arylamido-2-arylaminoprimidines as potent EGFR T790M/L858R inhibitors for NSCLC. Bioorganic & Medicinal Chemistry. 26(23-24). 6087–6095. 12 indexed citations
9.
10.
Liu, Zhihao, Dan Zhao, Changyuan Wang, et al.. (2017). Design, synthesis and biological evaluation of sulfonamide-substituted diphenylpyrimidine derivatives (Sul-DPPYs) as potent focal adhesion kinase (FAK) inhibitors with antitumor activity. Bioorganic & Medicinal Chemistry. 25(15). 3989–3996. 35 indexed citations
11.
12.
Zan, Gui‐Ying, Qian Wang, Yujun Wang, et al.. (2015). Antagonism of κ opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence. Behavioural Brain Research. 291. 334–341. 26 indexed citations
13.
Shu, Xiaohong, Lili Wang, Hong Li, et al.. (2015). Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications. Neurotherapeutics. 12(2). 491–501. 64 indexed citations
14.
Liu, Zhihao, Xiaokui Huo, Changyuan Wang, et al.. (2015). Enhancement effect of resveratrol on the intestinal absorption of bestatin by regulating PEPT1, MDR1 and MRP2 in vivo and in vitro. International Journal of Pharmaceutics. 495(1). 588–598. 21 indexed citations
15.
Sun, Zheng, Hong Li, Xiaohong Shu, et al.. (2013). Evaluation of resveratrol sensitivities and metabolic patterns in human and rat glioblastoma cells. Cancer Chemotherapy and Pharmacology. 72(5). 965–973. 17 indexed citations
16.
Li, Molin, Weiming Fu, Lulu Wo, et al.. (2013). miR-128 and its target genes in tumorigenesis and metastasis. Experimental Cell Research. 319(20). 3059–3064. 90 indexed citations
17.
Su, Zhaoan, et al.. (2012). Adverse Reaction in Patients with Drug Allergy History After Simultaneous Intravenous Fundus Fluorescein Angiography and Indocyanine Green Angiography. Journal of Ocular Pharmacology and Therapeutics. 28(4). 410–413. 46 indexed citations
18.
Wang, Qian Qian, Jingxin Ma, Xianghong Yang, et al.. (2011). CRABP‐II methylation: A critical determinant of retinoic acid resistance of medulloblastoma cells. Molecular Oncology. 6(1). 48–61. 33 indexed citations
19.
Huang, Li, et al.. (2007). Removal of ammonia from gas streams with dielectric barrier discharge plasmas. Journal of Hazardous Materials. 152(1). 113–119. 58 indexed citations
20.
Cai, Chun, et al.. (1999). [Schistosoma japonicum: protective immunity induced in mice immunized with SjGST-Sj32].. PubMed. 24(3). 225–8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Lapucci Breakdown of academic impact, for papers by Xinqun Li Breakdown of academic impact, for papers by Ye Xu Breakdown of academic impact, for papers by Clemens Zwergel Breakdown of academic impact, for papers by Anait S. Levenson Breakdown of academic impact, for papers by Tohru Yamamori Breakdown of academic impact, for papers by Yu‐Pei Yuan Breakdown of academic impact, for papers by Maria Luisa Panno Breakdown of academic impact, for papers by Junlian Gu
Rankless by CCL
2026